Late Phase clinical research is an extremely important to the development of a new drug or therapy. The knowledge needed the preparation and implementation of the these types of studies is crucial to the overall success of the study. This is why WCCT Global has been focusing on growing this arm of the company. Talia Nikolao, WCCT Global’s VP of Business Development stated, ” Its an exciting time at WCCT Global. The expansion of our late phase clinical research team is a testament to the success of our organization across many therapeutic areas. Our goal is to continually raise the bar for what is expected from a full service CRO.” WCCT Global has established a team specializing in late phase clinical research to offer clients years of experience in study design.
Check out the full press release about WCCT Global’s late phase clinical research expansion, Click Here